Celldex Therapeutics (CLDX) Depreciation & Amortization (CF) (2009 - 2026)
Celldex Therapeutics' Depreciation & Amortization (CF) came in at $902,000 for Q2 2026, up 3.3% from $873,000 a year earlier and up 5.6% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Celldex Therapeutics reported Depreciation & Amortization (CF) of $3.4 million, up 1.5% year-over-year; for FY2025, it came in at $3.38 million, up 6.4% from FY2024.
- Depreciation & Amortization (CF) has increased in each of the last three years, though with a five-year compound annual growth rate of -3.0% (FY2020 to FY2025).
- Going back by year, Depreciation & Amortization (CF) was $3.18 million in FY2024 (+5.6%), $3.01 million in FY2023 (+3.9%), $2.9 million in FY2022 (-5.6%) and $3.07 million in FY2021 (-21.9%).
- The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) since Q2 2020.
- Year-over-year, Depreciation & Amortization (CF) increased in six of the last eight quarters, with growth averaging 4.8%.
- The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q3 2023 (growth of 14.3%), and the weakest in Q4 2022 (a decline of 13.4%).
- Business Quant data shows CLDX's Depreciation & Amortization (CF) at $854,000 (Q1 2026), $816,000 (Q4 2025) and $824,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.58 Bn |
| 10 | Celldex Therapeutics | 2.41 Bn | 69.14 Mn | - | 1.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.16 Mn |
| Jun 30, 2026 | 902,000.00 |
| Mar 31, 2026 | 854,000.00 |
| Dec 31, 2025 | 816,000.00 |
| Sep 30, 2025 | 824,000.00 |
| Jun 30, 2025 | 873,000.00 |
| Mar 31, 2025 | 867,000.00 |
| Dec 31, 2024 | 819,000.00 |
| Sep 30, 2024 | 786,000.00 |
| Jun 30, 2024 | 797,000.00 |
| Mar 31, 2024 | 775,000.00 |
| Dec 31, 2023 | 759,000.00 |
| Sep 30, 2023 | 767,000.00 |
| Jun 30, 2023 | 756,000.00 |
| Mar 31, 2023 | 726,000.00 |
| Dec 31, 2022 | 673,000.00 |
| Sep 30, 2022 | 671,000.00 |
| Jun 30, 2022 | 741,000.00 |
| Mar 31, 2022 | 811,000.00 |
| Dec 31, 2021 | 777,000.00 |
API Access
Celldex Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();